Orphazyme A/S (ORPH) received a Notice of Allowance for its US patent application 16/879,198 titled "ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS" - PatentGrants
Get Alerts ORPH Hot Sheet
Join SI Premium – FREE
Orphazyme A/S (NASDAQ: ORPH) has received a Notice of Allowance for its US patent application 16/879,198 titled "ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS" - PatentGrants
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unilever (UL) to spin-off ice cream unit that includes Ben & Jerry's; shares up
- StoneCo (STNE) Announces Forthcoming Board of Directors Changes
- Atos (AEXAY) shares plummet 22% as Airbus kills BDS sale talks
Create E-mail Alert Related Categories
Corporate News, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!